Vanguard Group Inc Care Dx, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CDNA
# of Institutions
150Shares Held
55.1MCall Options Held
85.8KPut Options Held
48.8K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.86MShares$91.1 Million0.44% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$84.3 Million0.0% of portfolio
-
State Street Corp Boston, MA4.2MShares$65.2 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.93MShares$61.1 Million0.65% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$42.7 Million0.02% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $830M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...